122536-74-7 Usage
General Description
(S)-1-N-CBZ-3-N-BOC-AMINO PYRROLIDINE is a chemical compound that is commonly used in the pharmaceutical industry as a building block for the synthesis of various peptidomimetic compounds and potential drug candidates. It belongs to the class of pyrrolidine derivatives and is a versatile intermediate in organic synthesis. The compound is known for its chiral nature, and its use in the production of chiral pharmaceuticals and agrochemicals. It is often utilized as a key starting material for the preparation of various biologically active compounds due to its unique chemical reactivity and functional groups. Additionally, it has been studied for its potential antiviral and antifungal properties, making it an important molecule in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 122536-74-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,5,3 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 122536-74:
(8*1)+(7*2)+(6*2)+(5*5)+(4*3)+(3*6)+(2*7)+(1*4)=107
107 % 10 = 7
So 122536-74-7 is a valid CAS Registry Number.
122536-74-7Relevant articles and documents
Discovery of DS34942424: An orally potent analgesic without mu opioid receptor agonist activity
Arita, Tsuyoshi,Asano, Masayoshi,Domon, Yuki,Kubota, Kazufumi,Machinaga, Nobuo,Shimada, Kousei
, (2020/09/04)
We identified (5′S)-10′-fluoro-6′-methyl-5′,6′-dihydro-3′H-spiro[cyclopropane-1,4′-[2,6]diaza[2,5]methano[2,6]benzodiazonin]-7′(1′H)-one, 22b (DS34942424) with a unique and original bicyclic skeleton. 22b showed an orally potent analgesic in the acetic ac
TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS
-
Page/Page column 82, (2012/12/13)
Compounds of Formula I: in which R1, R2, R3, R4 and R10 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS
-
Page/Page column 114, (2008/06/13)
-